AIG
CYCN icon

American International Group’s Cyclerion Therapeutics CYCN Stock Holding History

American International Group’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-645
Closed -$36 – 3153
2021
Q1 		$36 Buy
645
+1
+0.2% +$75 ﹤0.01% 3050
2020
Q4 		$39 Sell
644
-18
-3% -$1.23K ﹤0.01% 3008
2020
Q3 		$81K Sell
662
-15
-2% -$1.72K ﹤0.01% 2637
2020
Q2 		$80K Sell
677
-22
-3% -$1.84K ﹤0.01% 2665
2020
Q1 		$37K Sell
699
-40
-5% -$2.85K ﹤0.01% 2794
2019
Q4 		$40K Sell
739
-7
-0.9% -$654 ﹤0.01% 2931
2019
Q3 		$181K Sell
746
-5
-0.7% -$1.08K ﹤0.01% 2230
2019
Q2 		$172K Buy
+751
New +$213K ﹤0.01% 2333

Other funds holding CYCN

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

American International Group's CYCN Position: Q2 2021 in Review

American International Group sold out of Cyclerion Therapeutics (CYCN) in Q2 2021, closing a stake of 645 shares — an estimated $36 sold.

American International Group first reported a position in CYCN in Q2 2019 and held it in 8 quarters. The position peaked at $181K in Q3 2019. 67 funds tracked by Wall St. Rank hold CYCN as of Q2 2021.

  • American International Group reported no remaining Cyclerion Therapeutics position as of Q2 2021 after selling out during the quarter.
  • American International Group sold 645 Cyclerion Therapeutics shares in Q2 2021, an estimated $36.
  • American International Group first reported a position in Cyclerion Therapeutics in Q2 2019 and held it in 8 quarters.
  • American International Group's Cyclerion Therapeutics position peaked at $181K in Q3 2019.
  • 67 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.